Sleep is an animal behaviour ubiquitously conserved from vertebrates to invertebrates, including flies and nematodes [1] [2] [3] , and is tightly regulated in a homeostatic manner. Sleep in mammals exhibits the cycles of REMS and NREMS that are defined by characteristic activity of electroencephalogram (EEG) and electromyogram (EMG). Time spent in sleep is determined by a homeostatic sleep need, a driving force for sleep/wakefulness switching, which increases during wakefulness and dissipates during sleep 4, 5 . The spectral power in the delta-range frequency (1-4 Hz) of EEG during NREMS has been regarded as one of best markers for the current level of sleep need. Conversely, the level of arousal is positively correlated with sleep latency, which can be regulated independently of sleep need 6 , reflecting the overall activity of wake-promoting neurons. Traditional approaches to locate the neural circuits regulating sleep and wakefulness behaviour included local ablation of brain regions [7] [8] [9] . Recent advances in optogenetic and chemogenetic research have directly demonstrated that switching between sleep and wake states is executed by subsets of neurons in the basal forebrain 10 , lateral hypothalamus 11,12 and locus coeruleus 13 , and that switching between NREMS and REMS is executed by a neural network in the pons and medulla 14, 15 . Despite the accumulating information about executive neural circuitries regulating sleep and wake states, the molecular and cellular mechanisms that determine the propensity of switching between wakefulness, REMS and NREMS remain unknown. To tackle this problem, we have used a phenotype-driven forward-genetics approach that is free from specific working hypotheses 16 . Previously, a series of forward-genetics studies using flies and mice successfully uncovered the molecular network of the core clock genes regulating circadian behaviours [17][18][19] . Sleep-regulating genes were also discovered through the screening of mutagenized flies 1,2 . However, genetic studies for sleep using mice has been challenging because of the effective compensation and redundancy in the regulation of sleep and wakefulness, and the need for EEG and EMG monitoring of the staging of wakefulness, NREMS and REMS.
Sleep is an animal behaviour ubiquitously conserved from vertebrates to invertebrates, including flies and nematodes [1] [2] [3] , and is tightly regulated in a homeostatic manner. Sleep in mammals exhibits the cycles of REMS and NREMS that are defined by characteristic activity of electroencephalogram (EEG) and electromyogram (EMG). Time spent in sleep is determined by a homeostatic sleep need, a driving force for sleep/wakefulness switching, which increases during wakefulness and dissipates during sleep 4, 5 . The spectral power in the delta-range frequency (1-4 Hz) of EEG during NREMS has been regarded as one of best markers for the current level of sleep need. Conversely, the level of arousal is positively correlated with sleep latency, which can be regulated independently of sleep need 6 , reflecting the overall activity of wake-promoting neurons. Traditional approaches to locate the neural circuits regulating sleep and wakefulness behaviour included local ablation of brain regions [7] [8] [9] . Recent advances in optogenetic and chemogenetic research have directly demonstrated that switching between sleep and wake states is executed by subsets of neurons in the basal forebrain 10 , lateral hypothalamus 11, 12 and locus coeruleus 13 , and that switching between NREMS and REMS is executed by a neural network in the pons and medulla 14, 15 . Despite the accumulating information about executive neural circuitries regulating sleep and wake states, the molecular and cellular mechanisms that determine the propensity of switching between wakefulness, REMS and NREMS remain unknown. To tackle this problem, we have used a phenotype-driven forward-genetics approach that is free from specific working hypotheses 16 . Previously, a series of forward-genetics studies using flies and mice successfully uncovered the molecular network of the core clock genes regulating circadian behaviours [17] [18] [19] . Sleep-regulating genes were also discovered through the screening of mutagenized flies 1, 2 . However, genetic studies for sleep using mice has been challenging because of the effective compensation and redundancy in the regulation of sleep and wakefulness, and the need for EEG and EMG monitoring of the staging of wakefulness, NREMS and REMS.
Sik3 splice mutation increases NREMS
We induced random point mutations into C57BL/6J (B6J) male mice (G 0 ) by ethylnitrosourea (ENU) and screened more than 8,000 heterozygous B6J × C57BL/6N (B6N) F 1 mice for dominant sleep and wakefulness abnormalities through EEG/EMG-based sleep staging (Extended Data Fig. 1a ). B6N was chosen as a counter strain because its sleep and wakefulness parameters are highly similar to B6J (Extended Data Fig. 1b) , and the entire list of single nucleotide polymorphisms has recently become available 20 . Through our screening, we established a mutant pedigree, which we termed Sleepy (Slp), with a markedly prolonged sleep time. Five founders of the Sleepy mutant pedigree were born by in vitro fertilization using sperm from the same ENU-treated G 0 male, and showed a daily wake time (524 ± 19.7 min; mean ± s.d.) that was shorter than the mean of all mice screened by > 3 standard deviations (Extended Data Fig. 1c ). The Sleepy pedigree showed clear dominant inheritance of reduced wake time (Fig. 1a) . Linkage analysis in the B6J × B6N N 2 generation of five Sleepy pedigrees (B021-B025) produced a single log Sleep is conserved from invertebrates to vertebrates, and is tightly regulated in a homeostatic manner. The molecular and cellular mechanisms that determine the amount of rapid eye movement sleep (REMS) and non-REMS (NREMS) remain unknown. Here we identify two dominant mutations that affect sleep and wakefulness by using an electroencephalogram/ electromyogram-based screen of randomly mutagenized mice. A splicing mutation in the Sik3 protein kinase gene causes a profound decrease in total wake time, owing to an increase in inherent sleep need. Sleep deprivation affects phosphorylation of regulatory sites on the kinase, suggesting a role for SIK3 in the homeostatic regulation of sleep amount. Sik3 orthologues also regulate sleep in fruitflies and roundworms. A missense, gain-of-function mutation in the sodium leak channel NALCN reduces the total amount and episode duration of REMS, apparently by increasing the excitability of REMS-inhibiting neurons. Our results substantiate the use of a forward-genetics approach for studying sleep behaviours in mice, and demonstrate the role of SIK3 and NALCN in regulating the amount of NREMS and REMS, respectively. odds ratio (LOD) score peak on chromosome 9 ( Fig. 1b and Extended Data Fig. 2a ), between rs13480122 (chr9: 31156626) and rs29644859 (chr9: 52785119) (Fig. 1b, c) . Whole-exome sequencing of Sleepy mutants identified a heterozygous single nucleotide substitution at the splice donor site (chr9: 46198712) for intron 13 of the Sik3 gene (Fig. 1d, e) . The mutation predicted an abnormal skipping of exon 13 (Sik3 Slp/+ ), which was confirmed by reverse transcription PCR (RT-PCR) and sequencing of the Sik3 mRNA (Fig. 1f, Supplementary  Fig. 1 and Extended Data Fig. 2b ).
SIK3 is a protein kinase that is broadly expressed in neurons of the cerebral cortex, thalamus, hypothalamus and brainstem (Extended Data Fig. 2c, d) , and belongs to the AMP-activated protein kinase (AMPK) family. SIK3 has a serine-threonine kinase domain at the N terminus and a protein kinase A (PKA) recognition site (Ser551) in the middle portion 21 (Fig. 1g) . The skipping of exon 13 results in an in-frame deletion of 52 amino acids, encompassing the PKA site (Fig. 1g , Extended Data Fig. 2e and Supplementary Fig. 1 ). Immunoblotting of brain homogenates from Sik3
Slp/+ and Sik3 Slp/Slp mice using anti-SIK3 antibody detected smaller SIK3 proteins as predicted (Fig. 1g, h and Supplementary Fig. 1 ). The nature of this mutation, taken together with our results on SIK3 orthologues in Drosophila melanogaster and Caenorhabditis elegans (see below), suggests that Sik3
Slp is a gain-of-function allele.
To confirm genetically that the Sik3 splice mutation is the sole cause of the long-sleep phenotype, we introduced the Sik3 exon 13-skipping allele into wild-type mice by using either conventional knock-in in embryonic stem (ES) cells or zinc-finger nuclease (ZFN) technology (Fig. 1i, Extended Data Fig. 3b and Supplementary Fig. 1 ). As expected, these mouse lines exhibited markedly reduced wake time (Fig. 1j , Extended Data Fig. 3c ), similar to the original Sleepy pedigree. Thus, the lack of exon 13 of the Sik3 gene causes the Sleepy phenotype.
Increased sleep need in Sleepy mutants
No overt abnormality in the sleep EEG/EMG was seen in the Sleepy mutants (Extended Data Fig. 4a ). Detailed examination of sleep and wakefulness behaviour of Sleepy mutants showed that, although
Sik3
Slp/+ mice exhibit reduced wake time and increased NREMS time both in the light and dark phases, the hypersomnia phenotype is more pronounced in the dark phase (Fig. 2a, b) , possibly owing to a ceiling effect in the light phase. Homozygous Sik3 Slp/Slp mice had an even shorter total wake time and longer NREMS time than Sik3
Slp/+ mice (Fig. 2a, b and Extended Data Fig. 4b-d Slp(ZFN)/+ mice (n = 15) showed a shorter total wake time than wild-type littermates (n = 14). * * * P < 0.001, two-way analysis of variance (ANOVA) followed by Tukey's test. Data are mean ± s.e.m.
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effect. Total REMS time was similar among genotype groups (Extended Data Fig. 4e ).
Sik3
Slp/+ and Sik3 Slp/Slp mice had a higher NREMS/total sleep ratio (Extended Data Fig. 4f ) and a lower REMS/total sleep ratio (Extended Data Fig. 4g ), indicating a NREMS-specific change in the Sleepy mutant mice. Longer time spent in REMS during the dark phase seems to be secondary to the increased sleep amount and be compensated with shorter REMS time during the light phase (Extended Data  Fig. 4h ). Female Sik3
Slp/+ and Sik3 Slp/Slp mice also exhibited a similar phenotype (Extended Data Fig. 4i) .
We next examined whether the short wake time of Sleepy mice is due to a defective wake-promoting response to behavioural or pharmacological stimuli. A new cage environment strongly mobilizes the wake-promoting system in mice 6 . Both Sik3 Slp/+ and Sik3
Slp/Slp mice exhibited prominent wake responses to cage change, similar to wild-type littermates during the light phase ( Fig. 2c ) and dark phase (Extended Data Fig. 5a ). Sik3 Slp/+ and Sik3 Slp/Slp mice also showed increased wake time in response to the administration of caffeine (Fig. 2d) or modafinil (Extended Data Fig. 5b) , to similar or even slightly higher degrees than Sik3 +/+ littermates. We then examined the behavioural circadian rhythm of the Sleepy mutants. The circadian period length as assessed by wheel-running behaviour under constant darkness was similar among genotype groups (Extended Data Fig. 5c ). Sleepy mutant mice showed a robust reduction in wake time also under constant darkness, similar to light-dark conditions (Extended Data  Fig. 5d ).
Given the apparently normal wake-promoting and circadian systems, we then proposed that the Sleepy mutants have an inherently higher sleep need. Indeed, Sleepy mutant mice exhibited a higher density of slow-wave activity during NREMS in an allele-dosage dependent fashion (Fig. 2e) , suggesting that the baseline sleep need is increased in the mutants. Lower-frequency power in EEG was also increased during wakefulness in Sleepy mutant mice (Extended Data Fig. 5e ), which may be associated with local cortical synchronization owing to increased sleep need 22 . Furthermore, 6 h of sleep deprivation from the onset of the light phase increased the NREMS delta power of Sik3 Slp mice to a larger extent than Sik3 +/+ mice (Fig. 2f ). To examine dose-dependent effects, we then conducted 2, 4 and 6 h of sleep deprivation. Under our conditions, Sik3 +/+ mice showed only a slight increase after 2 h of sleep deprivation, whereas Sik3
Slp/+ mice exhibited a marked dose-dependent increase in the delta power ( Fig. 2g and Extended Data Fig. 5f ), demonstrating their exaggerated response to sleep deprivation.
If SIK3 constitutes a part of the enigmatic molecular pathway determining the level of homeostatic sleep need, then the protein should be modulated by sleep deprivation. Because the function of SIK3 is regulated by its own phosphorylation 23 , we examined its phosphorylation status in the brain from mice in which a Flag-tag was inserted into the N terminus of SIK3 using CRISPR/Cas9 technology (Extended Data  Fig. 6a ). Immunoblotting and immunoprecipitation with anti-SIK3 and anti-Flag antibodies detected Flag-SIK3 protein in the brain as expected (Extended Data Fig. 6b-d and Supplementary Fig. 1 ). To examine whether sleep deprivation affects the phosphorylation status of SIK3, brains of Flag-Sik3 mice were obtained after sleep deprivation. Quantitative phosphoproteomic analysis of immunopurified Flagtagged proteins showed that sleep deprivation specifically increases the phosphorylation of residue Thr221, which is closely associated with the kinase activity of SIK3 (ref. 23; Fig. 2h ). In the same way, we introduced a Flag sequence into the Sik3 Slp allele, and obtained mice expressing mutant Flag-SIK3(SLP) protein (Extended Data Fig. 6b, c and Supplementary Fig. 1 ). In addition to the expected decrease in the phosphorylation of Ser551, Flag-SIK3(SLP) in the brains showed a decrease in the phosphorylation of Thr469, another PKA site 24 , and an increase in the phosphorylation of Ser914 compared with Flag-Sik3 mice under ad libitum sleep during the light phase (Extended Data  Fig. 5g ). After sleep deprivation, these phosphorylation changes were sustained and a significant increase in the phosphorylation of Ser674, another PKA site 24 , was recognized (Extended Data Fig. 5g) . Thus, the lack of the Ser551-containing region disturbs the phosphorylation status of other PKA sites in a complex fashion, suggesting a mechanistic link with the increased sleep need of Sleepy mutant mice.
Conserved role of SIK3 in invertebrates
The exon 13-encoded region of Sik3 is highly conserved among vertebrate animals (Fig. 3a) . Notably, there is a PKA recognition site within the exon 13-encoded region, which is conserved even in Sik3 orthologues of Drosophila and C. elegans ( Slp/+ (n = 32) and Sik3 Slp/Slp (n = 31) mice. * P < 0.05 (black); * P < 0.001 (red), one-way repeated measures ANOVA followed by Tukey's test. c, Time spent in wakefulness from zeitgeber time (ZT)4 to ZT5 after cage change at ZT5 of Sik3
Slp/+ (n = 9) and Sik3 Slp/Slp (n = 6) mice. * * * P < 0.001, one-way repeated measures ANOVA followed by Tukey's test. d, Wake time for 6 h after caffeine injection at ZT0 in Sik3 +/+ (n = 6), Sik3 Slp/+ (n = 6) and Sik3
Slp/Slp (n = 6) mice. * P < 0.05 (black); ##P < 0.01 versus 10 mg kg
body weight (BW); * P < 0.01 (red) versus 15 mg kg −1 BW, two-way ANOVA followed by Tukey's test. e, NREMS delta density of Sik3 mutant mice (Sik3 +/+ , n = 22; Sik3 Slp/+ , n = 32; Sik3 Slp/Slp , n = 31) across the lightdark cycle. * P < 0.05; * * * P < 0.001, one-way repeated ANOVA followed by Tukey's test. f, Increase in NREMS delta power of Sik3
Slp/+ (n = 7) and Sik3 Slp/Slp (n = 10) mice after 6-h sleep deprivation. * P < 0.05, one-way ANOVA followed by Tukey's test. g, Increase in NREMS delta power after 2, 4 and 6 h of sleep deprivation of Sik3
Slp/+ (n = 11) mice relative to NREMS delta power of the same ZT during basal sleep. * P < 0.05; * * P < 0.01; * * * P < 0.001, two-way ANOVA followed by Tukey's test. h, Phosphorylation of Flag-SIK3 of FlagSik3 +/+ brains with or without 4-h sleep deprivation. * P < 0.05, two-way ANOVA followed by Tukey's test. Data are mean ± s.e.m.
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after induction of SIK3(Ser563Ala) (Fig. 3b, c) . Conversely, flies with a hypomorphic Sik3 mutation showed reduced sleep time in the light-dark cycle and in constant darkness (Fig. 3d) . Furthermore, a null mutation of kin-29, the C. elegans orthologue of Sik3, reduced the fraction of quiescence during L4-adult lethargus, a sleep-like state in C. elegans 3 (Fig. 3e ). Pan-neuronal expression of kin-29 rescued this phenotype. Thus, orthologues of Sik3 also seem to be involved in the regulation of sleep amount in fruitflies and nematodes.
Nalcn mutation reduces REMS
The EEG/EMG-based dominant screening of ENU-mutagenized mice also yielded a mutant pedigree with a REMS abnormality, which we termed Dreamless (Drl). The founder of the pedigree showed a short REMS episode duration (Fig. 4a) , that was heritable in the offspring (Extended Data Fig. 8a ). Linkage analysis in the B6J × B6N N 2 generation showed a single LOD score peak near rs31233932 (chr14: 124108797) on chromosome 14 ( Fig. 4b and Extended Data Fig. 8b ). Whole-exome sequencing combined with direct sequencing of candidate genes identified a heterozygous missense mutation in the Nalcn gene (chr14: 123515403) as the only functionally relevant mutation within the mapped region in Dreamless mutants ( Fig. 4c and Extended Data Fig. 8c ). We then confirmed the causal relationship of the Nalcn gene mutation to the REMS phenotype by introducing the same nucleotide substitution in wild-type mice using the CRISPR/Cas9 system. CRISPR Nalcn Drl/+ mice showed a short REMS episode duration, similar to the original Dreamless pedigree (Fig. 4d-g ).
Dreamless mutants showed theta (6-9 Hz)-dominant EEG and appropriate muscle atonia during REMS, and did not show any overt abnormality in the EEG/EMG (Extended Data Fig. 9a) . Nalcn Drl/+ mice showed a reduced total REMS time owing to a short average REMS episode duration (Fig. 4d-g and Extended Data Fig. 9b, c) . In other words, Nalcn Drl/+ mice failed to maintain the REMS state properly, resulting in highly unstable REMS. The total time spent in the wake and NREMS states of Nalcn Drl/+ mice was similar to that of Nalcn +/+ mice (Extended Data Fig. 9d ). Nalcn Drl/+ mice had normal circadian period lengths but showed a greatly reduced amplitude of behavioural circadian rhythms under constant darkness (Extended Data Fig. 9e, f) , consistent with the recently reported involvement of NALCN in the circadian regulation of neuronal excitability in the suprachiasmatic nucleus 25 . A marked reduction in the REMS time of Nalcn Drl/+ mice was also observed under constant darkness (Extended Data Fig. 9g ). Spectral analysis of EEG showed a decrease in the theta-range power during NREMS and REMS and an increase in low-frequency power during the wake state and REMS in Nalcn Drl/+ mice (Extended Data Fig. 9h ), suggesting the possibility that NALCN may regulate various oscillations in the brain.
NALCN is a voltage-independent, non-selective cation channel with a proposed role in the control of neuronal excitability 26 . It is highly expressed in several brainstem nuclei involved in REMS regulation, such as the ventrolateral periaqueductal grey, deep mesencephalic nucleus (DpMe) and sublateral dorsal nucleus 7, 9, 14, 15 (Extended Data Fig. 10a-c) . The mutation results in an Asn315Lys substitution in helix S6 of domain I (Fig. 5a ), which is conserved among vertebrates and invertebrates (Fig. 5b) .
To examine whether the mutation changes the electrophysiological properties of NALCN, we made patch-clamp recordings from HEK293 cells cotransfected with NALCN or the NALCN(DRL) mutant, together with UNC80 and SRC(Tyr529Phe), which allow constitutive activation of NALCN 27, 28 . Both NALCN and NALCN(DRL) showed linear currentvoltage relationships (Fig. 5c, d and Extended Data Fig. 10d, e) , CT, circadian time. e, Sik3-null mutant worms, kin-29(oy38) (n = 15), exhibited reduced quiescence during lethargus compared with wild-type worms (n = 10). kin-29(oy38);P H20 ::kin-29 worms (n = 9), in which wildtype kin-29 was expressed in neuronal cells, restored normal quiescence during lethargus. The fractions of quiescence out of lethargus were similar (P = 0.98). * P < 0.05; * * P < 0.01; * * * P < 0.001, one-way repeated measures ANOVA followed by Tukey's test. Data are mean ± s.e.m. Drl/+ mice (n = 11) and Nalcn +/+ mice (n = 17) produced by CRISPR/Cas9 technology. * * * P < 0.001, two-tailed Student's t-test. Data are mean ± s.e.m.
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with similar equilibrium potentials (NALCN, − 2.1 ± 1.6 mV, n = 7; NALCN(DRL), − 1.2 ± 0.7 mV, n = 5, P = 0.94, Mann-Whitney U test). However, the ionic conductance of NALCN(DRL) was much larger than that of NALCN (Fig. 5e) . Similarly, the charge transfer of inward and outward currents in NALCN(DRL)-transfected cells was markedly higher than in NALCN-transfected cells (Extended Data Fig. 10f ), raising the possibility that NALCN(DRL) may increase the intrinsic excitability of REMS-regulatory neurons. To test this possibility, wholecell current-clamp recordings were made from neurons in the DpMe (Extended Data Fig. 10a ), which contains 'REM-off ' cells 15, 29, 30 , using brain slices from Nalcn Drl/+ and Nalcn +/+ mice. The DpMe neurons in Nalcn Drl/+ slices exhibited depolarization (Nalcn
, − 65.6 ± 1.7 mV, n = 33 cells; Nalcn Drl/+ , − 57.8 ± 2.0 mV, n = 31 cells; P = 0.01, MannWhitney U test) and higher spontaneous firing rates (Nalcn +/+ , 0.4 ± 2.3 spikes s , n = 31 cells; P = 0.03, Mann-Whitney U test) compared with Nalcn +/+ slices ( Fig. 5f-h ).
Discussion
Our EEG/EMG-based forward-genetics screen in mice has identified distinct sleep phenotypes and mutated genes. Yet our study also illustrates a conserved role of SIK3 in the sleep behaviour of vertebrates and invertebrates. We think that the Sleepy mutation in SIK3 increases the animal's intrinsic sleep need, because Sleepy mutant mice exhibit (1) a higher density of slow-wave activity, a reliable index of homeostatic sleep need; (2) a larger increase in NREMS delta power after sleep deprivation; and (3) a normal waking response to behavioural or pharmacological arousal stimuli. Furthermore, we found that the functionally relevant phosphorylation status of SIK3 is modulated by sleep deprivation, which induces an acute increase of sleep need. Taken together with the finding that the Sleepy mutation markedly increases the baseline NREMS amounts in an allele dosage-dependent fashion, we propose that SIK3 functions in the intracellular signalling pathway that dictates sleep need and homeostatically regulates the daily amount of sleep.
We propose that NALCN works in the neuronal groups regulating REMS 9, 14, 15 for the maintenance and termination of REMS episodes. The narrow abdomen mutant, carrying a loss-of-function mutation in the Drosophila orthologue of NALCN, exhibits increased sensitivity to anaesthesia 31 and abnormal circadian behaviour 32 in part through a blunted circadian change in neuronal excitability 25 . The crucial role of the narrow abdomen in enhancing bi-stability between wakefulness and the anaesthetized state, as well as between wakefulness and sleep 33 , is consistent with de-stabilized REMS episodes of the Dreamless mutant mice. Thus, like the case of SIK3 above, NALCN orthologues also appear to have conceptually analogous roles in regulating sleeprelated behaviours in both mice and fruitflies. Our results argue for the utility of unbiased forward-genetics screens for the discovery of genes, alleles and pathways regulating sleep in mammals.
Note added in proof: A related review article describing the neural circuitries controlling sleep and wake states can be found in ref. 34.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. , Sigma-Aldrich) by intraperitoneal injection twice at weekly intervals at the age of 8 weeks. At the age of 25-30 weeks, the sperm of the mice was used for in vitro fertilization with eggs of C57BL/6N mice to obtain F 1 offspring. Mice were provided food and water ad libitum, and were maintained on a 12-h light:12-h dark cycle and housed under controlled temperature and humidity conditions. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Tsukuba and the RIKEN BioResource Center, University of Texas Southwestern Medical Center at Dallas. Surgery. EEG/EMG electrode implantation was performed as described previously 35 , with isoflurane (3% for induction, 1% for maintenance) used for anaesthesia. Seven days after surgery, the mice were tethered to a counterbalanced arm (Instech Laboratories) that allowed free movement and exerted minimal weight. Screening scheme. At the age of 12 weeks, male mice were implanted with EEG/EMG electrodes and then screened for sleep/wakefulness behaviour. Examined parameters were total time spent in wake, NREMS and REMS states, episode duration of wake, NREMS and REMS states, appearance of muscle atonia during REMS, and rebound sleep after 4-h sleep deprivation by shaking the cages. For quantitative parameters, we selected mice whose phenotypes deviated from the average by at least 3 standard deviations. After confirming the reproducibility of the sleep phenotype, the mice were selected for offspring production by natural mating or IVF with wild-type females to examine the heritability of the sleep phenotypes. If at least 30% of the male littermates showed sleep phenotypes similar to their father, we considered the sleep abnormalities to be heritable. Linkage analysis. Single nucleotide polymorphisms of N 2 mice were determined using a custom TaqMan Genotyping assay (Thermo Fisher). The custom probes were designed based on the polymorphism data between C57BL/6J and C57BL/6N (ref. 20). QTL analysis was performed using J/qtl software (Jackson Laboratory). Whole-exome sequencing. Whole exomes were captured with SureSelectXT2 Mouse All Exon (Agilent) and processed to a paired end 2 × 100-bp run on the Illumina HiSeq2000 platform at the UTSW McDermott Center Next Generation Sequencing Core. Reads were mapped to the University of California Santa Cruz mm9 genome reference sequence for C57BL/6J using Burrows-Wheeler aligner and quality filtered using SAMtools. Cleaned BAM files were used to realign data and call variants using the Genome Analysis ToolKit to detect heterozygous mutations. Sleep behaviour analysis. The recording room was kept under 12-h light:12-h dark cycles and a constant temperature (24-25 °C). To examine sleep-wake behaviour under baseline conditions, EEG/EMG signals were recorded for two consecutive days from the onset of the light phase. EEG/EMG data were visualized and analysed using a MatLab (MathWorks)-based, custom semi-automated staging program followed by visual inspection. EEG signals were subjected to fast Fourier transform analysis from 1 to 30 Hz with 1-Hz bin using MatLab-based custom software. Epochs containing movement artefacts were included in the state totals but excluded from subsequent spectral analysis. Sleep/wakefulness was staged into wakefulness, NREMS and REMS. Wakefulness was scored based on the presence of low amplitude, fast EEG, and high amplitude, variable EMG. NREMS was characterized by high amplitude, delta (1-4 Hz) frequency EEG and low EMG tonus, whereas REMS was staged based on theta (6-9 Hz)-dominant EEG and EMG atonia. Hourly delta density during NREMS indicates hourly averages of delta density which is the ratio of delta power to total EEG power at each 20-s epoch. For the power spectrum of sleep/wakefulness, the EEG power of each frequency bins was expressed as a percentage of the total EEG power over all frequency bins (1-30 Hz) and sleep/wakefulness states 35, 36 . For sleep deprivation, mice were sleep deprived for 2, 4 and 6 h from the onset of the light phase by gently touching the cages when they started to recline and lower their heads. Food and water were available. To evaluate the effect of sleep deprivation, the NREMS delta power during the first hour after sleep deprivation was expressed relative to the same zeitgeber time (ZT) of the basal recording or relative to the mean of the basal recording. For caffeine and modafinil injection experiments, mice were fully acclimatized for intraperitoneal injection before sleep recording. After 24-h baseline recording, mice received caffeine (Sigma), modafinil (Sigma) or vehicle (0.5% methyl cellulose (Wako)) intraperitoneally at ZT0, followed by 12-h recording. Injections were delivered once per week, with each injection followed by a 6-8-day washout period, during which mice remained in the recording chamber. To examine the sleep/wakefulness behaviour under constant darkness, after 48-h recording under a 12-h light:12-h dark cycle, EEG/EMG recording continued in constant darkness for 3 days. Circadian behaviour analysis. Mice were housed individually in a cage (width 23 cm, length 33 cm, height 14 cm) containing a wireless running wheel (Med Associate ENV-044). Cages were placed in a light-tight chamber equipped with green LED light (100 lx at the bottom of the cage). The rotation numbers of wheels were obtained with 1-min bin using Wheel manager software (Med Associate). Mice were entrained to 12-h light:12-h dark cycle for 7 days, and then released into constant darkness for 3 weeks. The free running period was calculated with linear regression analysis of activity onset using MatLab-based custom software. Circadian activity amplitude was calculated by fast Fourier transform of activity data, which were processed with Bartlett window using MatLab-based custom software. Relative amplitude was normalized to the mean amplitude of the wildtype group. Western blot. A rabbit polyclonal antibody against the C-terminal 171 amino acids of mouse SIK3 was generated using custom antibody production service (Pacific Immunology). Tissues were homogenized using a rotor-stator homogenizer (Polytron) in ice-cold lysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM Na 4 P 2 O 7 , 1.5% Triton X-100,15 mM NaF, 1× PhosSTOP (Roche), 5 mM EDTA, 1× protease inhibitor (Roche)), and then centrifuged at 13,000g at 4 °C. The supernatants were separated by SDS-PAGE and transferred on PVDF membrane. Western blotting was performed according to standard protocols. In situ hybridization. In situ hybridization was performed as described previously 37 . In brief, a 0.7-0.8-kb fragment of Nalcn cDNA was inserted into pGEM-T easy (Promega) and used for DIG-labelled probe synthesis. Mice were deeply anaesthetized with sodium pentobarbital and perfused transcardially with PBS followed by 4% paraformaldehyde (PFA). Forty-micrometre-thick brain sections were treated with 0.3% Triton X-100, digested with 1 μ g ml −1 proteinase K, treated with 0.75% glycine, and then treated with 0.25% acetic anhydride in 0.1 M triethanolamine. After overnight incubation with a digoxigenin (DIG)-labelled probe at 60 °C, the sections were washed and then incubated with alkaline phosphatase-conjugated anti-DIG Fab fragments (Roche, 11175041910). The reactions were visualized with a 5-bromo-4-chloro-3-indolyl-phosphate/4-nitroblue tetrazolium (BCIP/NBT) substrate solution (Roche). Cell lines. HEK293 cells (RCB1637) and HEK293T cells (RCB2202) were obtained from the RIKEN BRC Cell Bank. Cells were cultured in DMEM (Wako) supplemented with 10% FBS, 1% GlutaMAX (Thermo Fisher Scientific), and penicillin/ streptomycin at 37 °C in a humidified atmosphere of 5% CO 2 . Cell lines were regularly tested for mycoplasma contamination using MycoAlert (Lonza). Cell lines were regularly renewed by obtaining cell stocks from the Cell Bank for authentication. We used HEK293 and HEK293T cells because of their reliable growth, high efficiency in transfection and morphology suitable for electrophysiological experiments.
Production of Sik3 gene-modified mice by conventional gene targeting. For generating Sik3
Slp knock-in mice, a genomic fragment containing exon 13 of the Sik3 gene was isolated from C57BL/6 mouse genomic BAC clone from a RP23 mouse genomic BAC library (Advanced GenoTEchs Co). A 1.7-kb fragment of FRT-PGK-gb2-neo-FRT-loxP cassette (Gene Bridges) flanked by two flippase recognition target (FRT) sites was inserted before exon 12. The targeting vector also contains a G-to-A substitution at the fifth nucleotide from the beginning of intron 13. The targeting vector was linearized and electroporated into the C57BL/6N ES cell line RENKA. Correctly targeted clones were injected into eight-cell stage ICR mouse embryos, which were cultured to produce blastocysts and then transferred to pseudopregnant ICR females. Resulting male chimaeric mice were crossed with female C57BL/6N mice to establish the Sik3 Slp-neo/+ line. To remove the neomycin resistance gene with the FLP-FRT system, Sik3
Slp-neo/+ mice were crossed with Actb-FLP knock-in mice. Production of Sik3 gene-modified mice using ZFN. The custom-designed ZFN mRNAs targeting the exon 13-intron 13 boundary region of the Sik3 gene were obtained from Sigma-Aldrich's Composers Custom ZFN service. Before the final assembly of the ZFN products, Sigma-Aldrich validated the designed ZFN binding sequences in silico using their bioinformatics tools and in vitro using Nero2A cell lines, ensuring high cutting efficiency and specificity using mismatch-specific endonuclease CelI according to the manufacturer's instructions. The ZFN mRNAs were injected into single-cell stage C57BL/6J mouse zygotes at the University of Texas Southwestern Transgenic Core facility. The injected eggs were then transferred to pseudopregnant females to generate F 0 founders. In total, 45 out of 96 F 0 mice were found to be modified at the exon 13-intron 13 boundary region of the Sik3 gene. We crossed one F 0 male mouse that had a 2-bp deletion from the last nucleotide of exon 13 with female C57BL/6N mice to obtain F 1 mice of Sik3
Slp/+ ZFN. The F 1 mice were used to confirm the skipping of exon13 in Sik3 mRNA, which was purified from the brains and livers. The F 2 male mice were used for sleep/wakefulness behaviour analysis. Production of Flag-Sik3 mice and Nalcn DRL mice by CRISPR/Cas9 technology. To produce a Cas9/single-guide RNA (sgRNA) expression vector, oligonucleotide DNAs (5′ -CACCGCGAGCGGCCATCGACCCGC-3′ and 5′ -AAACGC GGGTCGATGGCCGCTCGC-3′ ) were annealed and then inserted into pX330 ARTICLE RESEARCH vector (Addgene). The cleavage activity of the pX330-Sik3Ex1 vector was evaluated by the EGxxFP system 38 . Genomic DNA containing exon 1 of the Sik3 gene was amplified and inserted into pCAG-EGxxFP to produce pCAG-EGxxFP-Sik3Ex1. The pX330-Sik3Ex1 and pCAG-EGxxFP-Sik3Ex1 were transfected into HEK293 cells. As a donor oligonucleotide, a single-stranded 200-nucleotide DNA was synthesized (Integrated DNA Technologies), which contained a Flag-haemagglutinincoding sequence in the centre and 70-nucleotide arms at the 5′ and 3′ ends. Female C57BL/6J mice or Sik3
Slp knock-in mice were injected with pregnant mare serum gonadotropin and human chorionic gonadotropin at a 48-h interval, and mated with male C57BL/6J mice. The fertilized one-cell embryos were collected from the oviducts. Then, 5 ng μ l −1 of pX330-Sik3Ex1 vector and 10 ng μ l −1 of the donor oligonucleotide were injected into the pronuclei of these one-cell-stage embryos. The injected one-cell embryos were then transferred into pseudopregnant ICR mice. F 0 mice were genotyped for the presence of Flag-coding sequence in exon1 of the Sik3 gene and for the presence of the Sik3 Slp mutation. F 0 mice containing Flag-SIK3 were further examined for the presence of the Cas9 transgene and off-target effects. Candidate off-target sites were identified based on a complete match of 16 bp at the 3′ end, including the PAM sequence. F 0 mice were mated with C57BL/6N mice to obtain F 1 offspring.
Nalcn Drl mice were produced as described above. To produce the sgRNA expression vector, pX330-NalcnEx9, oligonucleotide DNAs (5′ -CACCA GCAATAAACACATTCTGAA-3′ and 5′ -AAACTTCAGAATGTGTTTA TTGCT-3′ ) were used. Genomic DNA containing exon 9 of the Nalcn gene was amplified and inserted into pCAG-EGxxFP to produce pCAG-EGxxFP-NalcnEx9. As a donor oligonucleotide, a single-stranded 199-nucleotide DNA containing a T-to-A substitution at the centre was synthesized (Integrated DNA Technologies). Nalcn mutant mice of N 2 -N 3 generation were used for sleep/wakefulness analysis. Phosphoproteomic analysis. To evaluate Flag-tagged SIK3 protein in brains, we performed peptide mapping of the purified Flag-SIK3 protein. The brains of Flag-Sik3 knock-in mice and Flag-Sik3
Slp knock-in mice were quickly dissected after cervical dislocation. Brains were homogenized in detergent-free buffer and then centrifuged (100,000g, 30 min, 4 °C). The supernatant was immunoprecipitated with anti-DDDDK antibody beads (MBL 3325). The eluate was run on a polyacrylamide gel and stained with SilverQuest Silver staining kit (Life technologies). Flag-SIK3 band (150 kDa) was dissected with a fresh blade. The proteins in the bands were reduced with 10 mM dithiothreitol and alkylated with 40 mM iodoacetamide. Each sample was digested with trypsin (4 μ g ml ; Trypsin Gold, Promega) at 37 °C overnight. The extracted peptides were then separated via nano flow LC (Advance LC, Michrom Bioresources) using a C18 column. The LC eluate was coupled to a nano-ionspray source attached to a Orbitrap Velos Pro mass spectrometer (Thermo Fisher Scientific). All MS/MS spectra were searched using Proteome Discoverer 1.3 software (Thermo Fisher Scientific). Peptides were mapped through mouse SIK3 (NP_081774) with 56% coverage.
To examine the effect of sleep deprivation on the phosphorylation status of SIK3 protein, five Flag-Sik3 knock-in mice or five Flag-Sik3
Slp knock-in mice were ad libitum slept (S) or sleep-deprived (SD) for 4 h by gentle handling immediately after light onset (ZT0-ZT4). Five wild-type mice were used as a negative control. At ZT4, mouse brains were quickly dissected after cervical dislocation, rinsed with cold PBS, and snap frozen in liquid nitrogen. Each half of the brains was lysed in 2 ml of ice-cold lysis buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2 mM MgCl 2 , 15 mM NaF, 10 mM Na 4 P 2 O 7 ) freshly supplemented with protease/phosphatase inhibitor cocktail tablets (Roche), and homogenized in a glass tissue homogenizer. After brain homogenate was incubated for 30 min and centrifuged at 13,000g for 20 min at 4 °C, the supernatant was precleared by IgG and Protein G beads for 30 min before immunoprecipitation. Each pre-cleared lysate was added to 50 μ l of anti-Flag antibody-conjugated Sepharose beads (Sigma, A2220) and rotated overnight at 4 °C. After washing the beads five times with cold wash buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2 mM MgCl 2 , 15 mM NaF, 10 mM Na 4 P 2 O 7 ), 50 μ l of elution buffer (2% SDS, 60 mM Tris-HCl, pH 6.8, 50 mM DTT, 10% glycerol) was added and rotated for 10 min at 4 °C. Elution was repeated twice and combined into one eluate and analysed by western blotting. For each group of Flag knock-in mice, the five eluates of were mixed and equally split into two or three samples for mass spectrometric analysis. Thus, a total of six (Flag-Sik3) or nine (Flag-Sik3 and Flag-Sik3 Slp ) samples were reduced, alkylated, and trypsin digested overnight. After desalting, each sample was labelled with a different Tandem Mass Tag (TMT) reagent (Thermo Fisher Scientific), then all samples were combined into one mixture for HPLC fractionation using a C18 column. A total of 12 fractions were collected, and analysed separately on the Orbitrap-Fusion mass spectrometry platform (Thermo Fisher Scientific) using a reverse-phase liquid chromatography tandem mass spectrometry (LC-MS/MS) method. We performed data analysis to identify peptides and quantified reporter ion relative abundance using Proteome Discoverer 2.1 (Thermo Fisher Scientific). The relative abundance of quantified SIK3 phosphorylation sites was normalized with wild-type negative control and total SIK3 protein abundance. Patch-clamp recordings from HEK cells. To express wild-type NALCN, we used pTracer-CMV2-ratNALCN-EF1α -EGFP (a gift from D. Ren) 39 . A single nucleotide substitution was induced to make pTracer-CMV2-ratNALCN(DRL)-EF1α -EGFP using a KOD plus Mutagenesis kit (Toyobo). HEK293T cells were grown to ~ 50% confluency in 12-well plates. Using Lipofectamine LTX (2 μ l) and PLUS (1 μ l) reagents (Thermo Fisher Scientific), the cells were cotransfected with 0.3 μ g of each plasmid DNA encoding rat NALCN-EGFP (wild type or DRL), mouse UNC-80, and mouse SRC (Y529F) (constitutively active Src) in 12-well plates. UNC-80 and SRC kinase activate NALCN 27, 28 . In some experiments, the cells were incubated with 10 μ M Gd 3+ to inhibit NALCN. The cells were dissociated and plated on 18-mm coverslips coated with poly-l-lysine in fresh culture medium before patch-clamp recordings.
All patch-clamp recordings from HEK293T cells were performed > 72 h after transfection. Recording patch pipettes were pulled from glass capillaries (1B150F-4, World Precision Instruments) using a micropipette puller (P-97, Sutter Instrument) to give a resistance of ~ 9 MΩ. The series resistance of whole-cell recordings was ~ 40 MΩ, which was not compensated. Patch pipettes were filled with solution containing 150 mM CsOH, 120 mM methanesulfonic acid, 10 mM NaCl, 10 mM EGTA, 2 mM Mg 2 ATP and 10 mM HEPES (pH 7.4 adjusted with methanesulfonic acid; osmolarity, 290− 299 mOsm l −1 adjusted with CsCl). The cells on coverslips were transferred to a recording chamber under a fluorescence upright microscope (Axio Examiner D1, Zeiss) and continuously perfused with the bath solutions containing 150 mM NaCl, 3.5 mM KCl, 10 mM HEPES, 20 mM glucose, 5 mM NaOH, 2 mM MgCl 2 and 1.2 mM CaCl 2 (pH 7.4 adjusted; osmolarity, 300− 310 mOsm l
−1
). The transfected cells were identified by enhance green fluorescent protein (eGFP) fluorescence. Patch-clamp recordings were performed at room temperature (24 °C) using a computer-controlled amplifier (MultiClamp 700B, Molecular Devices). The signals were digitized with A/D converter (Digidata 1440A, Molecular Devices), and acquired with Clampex (Molecular Devices) at a sampling rate of 50 kHz, and low-pass filtered at 5 kHz. At the end of recording, Gd 3+ (10 μ M) was used to confirm that the whole-cell currents were mediated through NALCN 39 . Data were analysed using Clampfit (Molecular Devices). The equilibrium potentials were calculated from I-V curves. Mean membrane conductance was estimated from the regression lines fitted to I-V curves from individual cells. Current, membrane conductance and charge transfer were normalized to membrane capacitance. Patch-clamp recordings from neurons. Patch pipettes and recording system were the same as those used in recordings from HEK293 cells. Acute brain slices containing the DpMe were prepared from post-natal day 12-23 Nalcn +/+ or Nalcn Drl/+ mice. After the induction of deep anaesthesia with isoflurane, mice were decapitated and the brains were rapidly removed into an ice-cold cutting solution containing 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 25 mM glucose, 185 mM sucrose, 0.5 mM CaCl 2 and 10 mM MgCl 2 (pH 7.4, when bubbled with 95% O 2 and 5% CO 2 ). The brains were cut coronally into 200-250 μ m-thick slices with a vibratome (VT-1200S, Leica). The slices were incubated at 37 °C for 1 h in artificial cerebrospinal fluid (aCSF) containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 10 mM glucose, 2 mM CaCl 2 and 1 mM MgCl 2 (pH 7.4, when bubbled with 95% O 2 and 5% CO 2 ) before recordings. Slices were transferred to a recording chamber perfused with aCSF under an upright microscope (Axio Examiner D1, Zeiss). Patch pipettes were filled with solution containing 125 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 0.5 mM EGTA, 8 mM phosphocreatine-Na 2 , 4 mM ATP-Mg and 0.3 mM GTP-Na (pH 7.3 adjusted with KOH; osmolality, 290 mOsm l elav-GS (GeneSwitch) stocks were from the Bloomington stock centre. Flies were reared at 25 °C under 12-h light:12-h dark cycle in 50-60% relative humidity on a standard fly food consisting of corn meal, yeast, glucose, wheat germ and agar.
Sleep analysis was performed as described previously 41 . In brief, male flies (2-5 days old) were individually housed in glass tubes (length, 65 mm; inside diameter, 3 mm) containing standard fly food at one end and a cotton plug on the other end. Sucrose-agar (1% agar supplemented with 5% sucrose) food was used for the GeneSwitch system assay, instead of standard food. The glass tubes were placed in the Drosophila activity monitor (DAM) (Trikinetics) and the locomotor activity of each fly was recorded as the number of infrared beam crossings in 1-min bin. Sleep was defined as periods of inactivity lasting 5 min or longer. Sleep assay were performed for 3 d under 12-h light:12-h dark cycle conditions and then constant darkness conditions. For 12-h light:12-h dark cyles, zeitgeber time (ZT) was used, and for constant darkness, circadian time (CT), with CT0 as 12 h after lights-off of the last 12-h light:12-h dark conditions, was used to indicate the daily time.
For conditional expression analysis, we used the GeneSwitch system 42 where expression is induced by a steroid hormone antagonist RU486. Flies are monitored for 3 days in tubes without drug in constant darkness and then transferred to new tubes either with vehicle (0.5% DMSO) alone or with 0.5 mM RU486 and then further monitored under constant darkness conditions. The expression of endogenous or transgenic Sik3 genes was confirmed by RT-PCR using RNA from fly heads. Nematode strains and quiescence assay. The wild-type strain N 2 and the mutant strain PY1479 kin-29(oy38) X were obtained from the Caenorhabditis Genetics Center (CGC) 43 . All worms were maintained at 20 °C on nematode growth medium (NGM) agar plates seeded with E. coli HB101. For construction of P H20 ::kin-29, kin-29 cDNA was amplified by RT-PCR and inserted into the plasmid pPD-DEST (a gift from Y. Iino) to generate pDEST-KIN-29. Next, we carried out the LR-recombinase reaction (Gateway System, Life Technologies) between pENTR-P H20 (a gift from Y. Iino) and pDEST-KIN-29 to generate P H20 ::kin-29. P H20 ::kin-29 was injected at 30 ng μ l −1 together with the injection marker P myo-3 ::mcherry (10 ng μ l ) into the kin-29(oy38) mutant worms.
Quiescence during the L4 to adult lethargus was measured using the microfluidic-chamber based assay 44 . In brief, polydimethylsiloxane-made microfluidic chambers containing liquid NGM and the E. coli HB101 were loaded with early L4 larvae and sealed with a cover glass plus 2% agarose, and set under the microscope. Images were taken every 2 s for 12 to 20 h at 20 ± 0.5 °C using the microscope M205FA (Leica) equipped with the camera MC120HD (Leica) (pixel size: 1,024 μ m × 768 μ m) controlled by Leica Application Suite V4.3 or the microscope SZX16 (Olympus) equipped with the camera GR500BCM2 (Shodensha) (pixel size: 1,024 μ m × 768 μ m) controlled by μ Manager (UCSF). Subtraction between serial images was carried out using Image J, and worms were regarded as quiescent at a specific time point if the difference from the preceding time point was less than 1% of the total body size. The fraction of quiescence was defined as the number of quiescent time points divided by the total number of time points during a period of 10 min.
The onset of lethargus quiescence was defined as the time point after which the fraction of quiescence was higher than 0.05 for at least 20 min, whereas the end point was defined as the time point after which the fraction of quiescence was lower than 0.05 for at least 20 min. Occasionally, brief episodes of quiescence were observed outside of lethargus both in wild-type and mutant worms; these episodes were excluded by setting a threshold of 60 min for the minimum duration of lethargus quiescence. Statistics. Sample sizes were determined using R software based on averages and standard deviations that were obtained from small scale experiments. No method of randomization was used in any of the experiments. The experimenters were blinded to genotypes and treatment assignment. Statistical analysis was performed using SPSS Statistics 22 (IBM) and R software. All data were tested for Gaussian distribution and variance. Homogeneity of variances was tested with Levene's test. We used Student's t-test for pairwise comparisons, one-way ANOVA for multiple comparisons, one-way repeated measure ANOVA for multiple comparisons with multiple data points, and two-way ANOVA for multiple comparisons involving two independent variables. ANOVA analyses were subjected to Tukey's post-hoc test. When deviation from normality and lack of homogeneity of variances occurred (P < 0.05), Mann-Whitney U test was used for group comparison. P < 0.05 was considered statistically significant. Data availability. The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
